She has been worked in Cardiovascular Medicine for 14 years, and been appointed a member of the board of directors of Daqing Branch of Medical Association for Hypertension, National Center for Cardiovascular Diseases. Also, she is a member of Professional Committee on Prevention and Management of Thrombosis and Embolism Diseases of Shenzhen Hospital Association, a member of Daqing Medical Association for Cardiac Rehabilitation, and a member of Heilongjiang Provincial Committee of Combined Traditional Chinese and Western Medicine and Critical Care Medicine. Proficiency: Differential diagnosis, adjustment of antihypertensive regime and fine management of primary hypertension and secondary hypertension; Drug treatment and rehabilitation management of coronary heart disease, atrial fibrillation, cardiac insufficiency and other diseases. She has undertaken a number of scientific research projects, including Mini-culotte Procedure for the Treatment of Coronary Bifurcation Lesions, Predictive Value of Related Risk Factors for Subclinical Atherosclerosis by Hierarchical Logistic Regression Analysis, Application of Aortic Balloon Counterpulsation (IABP) in Left Main Artery Disease, which won the first prize for Science and Technology Progress in Daqing; and other projects like Application of Embedding Balloon in Lateral Branch in Percutaneous Coronary Intervention for True Bifurcation Lesions, Three Dimensional Electroanatomic Mapping combined with V2R Wave Event Index Radiofrequency Ablation of Outflow Tract Ventricular Premature Beats, Application of Serum Homocysteine in Young and Middle-aged Men with Hypertension and Erectile Dysfunction won many awards for medical and health new technology application in Heilongjiang province. She has published more than 10 articles and 2 treatises, and serves as deputy editor in chief of Diagnosis and Treatment of Medical Diseases, and chief editor of Clinical Diagnosis and Treatment of Cardiology. She obtained the GCP Certificate in 2007, and has successively undertaken many global multicenter clinical trials of drugs.